These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 572405)

  • 21. Ocular disease resulting from infection with Rift Valley fever virus.
    Siam AL; Meegan JM
    Trans R Soc Trop Med Hyg; 1980; 74(4):539-41. PubMed ID: 7192443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of real-time RT-PCR for the detection of low concentrations of Rift Valley fever virus.
    Maquart M; Temmam S; Héraud JM; Leparc-Goffart I; Cêtre-Sossah C; Dellagi K; Cardinale E; Pascalis H
    J Virol Methods; 2014 Jan; 195():92-9. PubMed ID: 24120571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on goats experimentally infected with R.V.F. virus.
    Iman IZ; el-Karamany R; Kasem S
    J Egypt Public Health Assoc; 1978; 53(3-4):273-80. PubMed ID: 752709
    [No Abstract]   [Full Text] [Related]  

  • 24. Seriologic and vector comparisons of Rift Valley virus with other bunyaviruses.
    Shope RE
    J Egypt Public Health Assoc; 1978; 53(3-4):235-42. PubMed ID: 752702
    [No Abstract]   [Full Text] [Related]  

  • 25. Recurrence of Rift Valley fever in Egypt.
    Arthur RR; el-Sharkawy MS; Cope SE; Botros BA; Oun S; Morrill JC; Shope RE; Hibbs RG; Darwish MA; Imam IZ
    Lancet; 1993 Nov; 342(8880):1149-50. PubMed ID: 7901480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rift Valley fever in rural northern Senegal: human risk factors and potential vectors.
    Wilson ML; Chapman LE; Hall DB; Dykstra EA; Ba K; Zeller HG; Traore-Lamizana M; Hervy JP; Linthicum KJ; Peters CJ
    Am J Trop Med Hyg; 1994 Jun; 50(6):663-75. PubMed ID: 7912905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of antibody to Rift Valley fever virus in the Nile river delta of Egypt, 13 years after a major outbreak.
    Corwin A; Habib M; Watts D; Olson J; Darwish M; Hibbs R; Botros B; Kleinosky M; Shope R; Kilpatrick M
    Trans R Soc Trop Med Hyg; 1993; 87(2):161. PubMed ID: 8337715
    [No Abstract]   [Full Text] [Related]  

  • 28. Tracking Rift Valley fever: From Mali to Europe and other countries, 2016.
    Tong C; Javelle E; Grard G; Dia A; Lacrosse C; Fourié T; Gravier P; Watier-Grillot S; Lancelot R; Letourneur F; Comby F; Grau M; Cassou L; Meynard JB; Briolant S; Leparc-Goffart I; Pommier de Santi V
    Euro Surveill; 2019 Feb; 24(8):. PubMed ID: 30808441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of reverse transcriptase PCR in early diagnosis of Rift Valley fever.
    Sall AA; Macondo EA; Sène OK; Diagne M; Sylla R; Mondo M; Girault L; Marrama L; Spiegel A; Diallo M; Bouloy M; Mathiot C
    Clin Diagn Lab Immunol; 2002 May; 9(3):713-5. PubMed ID: 11986283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rift Valley fever in kidney transplant recipient returning from Mali with viral RNA detected in semen up to four months from symptom onset, France, autumn 2015.
    Haneche F; Leparc-Goffart I; Simon F; Hentzien M; Martinez-Pourcher V; Caumes E; Maquart M
    Euro Surveill; 2016 May; 21(18):. PubMed ID: 27172608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rift Valley fever].
    Pépin M;
    Med Mal Infect; 2011 Jun; 41(6):322-9. PubMed ID: 21295425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of techniques for demonstrating antibodies to Rift Valley fever virus.
    Swanepoel R; Struthers JK; Erasmus MJ; Shepherd SP; McGillivray GM; Erasmus BJ; Barnard BJ
    J Hyg (Lond); 1986 Oct; 97(2):317-29. PubMed ID: 3537118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of Rift Valley fever virus from human peripheral blood mononuclear cells: Mauritanian epidemic.
    Sarthou JL; Jouan A; Le Guenno B; Philippe B; Riou O; Lena P; Knauert FK; Peters CJ; Digoutte JP
    Res Virol; 1989; 140(3):263-70. PubMed ID: 2667067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Filter paper confetti in a serological Rift Valley fever survey.
    Jouan A; Coulibaly I; Lena P; Sarthou JL; Leguenno B; Meegan J; Ksiazek T
    Res Virol; 1989; 140(2):169-73. PubMed ID: 2667065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of an IgM antibody capture ELISA based on a recombinant nucleoprotein for identification of domestic ruminants infected with Rift Valley fever virus.
    Williams R; Ellis CE; Smith SJ; Potgieter CA; Wallace D; Mareledwane VE; Majiwa PA
    J Virol Methods; 2011 Nov; 177(2):140-6. PubMed ID: 21827790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling the spatial spread of Rift Valley fever in Egypt.
    Gao D; Cosner C; Cantrell RS; Beier JC; Ruan S
    Bull Math Biol; 2013 Mar; 75(3):523-42. PubMed ID: 23377629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and serological studies on the Rift Valley fever outbreak in Mauritania in 2010.
    Jäckel S; Eiden M; El Mamy BO; Isselmou K; Vina-Rodriguez A; Doumbia B; Groschup MH
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():31-9. PubMed ID: 24589099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An inactivated rift valley fever vaccine.
    Barnard BJ; Botha MJ
    J S Afr Vet Assoc; 1977 Mar; 48(1):45-8. PubMed ID: 874947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A seroepidemiological study for Rift Valley fever virus in humans and domestic animals in Egypt.
    Darwish MA; Imam IZ; Omar F
    J Egypt Public Health Assoc; 1978; 53(3-4):153-62. PubMed ID: 752699
    [No Abstract]   [Full Text] [Related]  

  • 40. Rift Valley Fever. A survey for antibody to the virus in bird species commonly found in situations considered to be enzootic.
    Davies FG; Addy PA
    Trans R Soc Trop Med Hyg; 1979; 73(5):584-5. PubMed ID: 531912
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.